ARCHIVES

IOM Calls FDA Advisory System Sounds, Suggests Conflict Criteria Changes

This article is from The Cancer Letter archive.

Vol. 19 No. 10 | March 5, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Moves to Regulate Lab-Developed Tests

August 1, 2014

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000

No Cancer Letter for Two Weeks

August 13, 1993

Obituary: Ruth Kirschstein, 82, NIH Administrator, Scientist, Mentor. House Member Softens Breast Cancer Bill

October 9, 2009

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

Comprehensive Centers Should Emphasize New Treatment, Group Says

July 27, 1979